Description
A competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.5 and 0.1 μM for AMPA and kainate receptors, respectively versus IC50 = 40 μM for NMDA receptors); used to target AMPA and kainate receptor responses and thus differentiate from that of NMDA receptors
Formal name: 1,4-dihydro-6,7-dinitro-2,3-quinoxalinedione
Synonyms: 6,7-Dinitroquinoxaline-2,3-dione|FG 9041
Molecular weight: 252.1
CAS: 2379-57-9
Purity: ≥95%
Formulation: A solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Neuroscience